PHENOBARBITAL SODIUM MSDS - AN OVERVIEW

pentobarbital will minimize the extent or effect of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Usage of naloxegol with sturdy CYP3A4 inducers will not be advisedpentobarbital will decrease the level or effect of atogepant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of